Add to ORKGIntroduction: Transcranial magnetic stim-ulation (TMS) is a novel antidepressant therapy shown to be effective and safe in pharmacotherapy-resistant major depres-sion. The incremental cost-effectivenes
AbstractBackgroundPrefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6...
Objective: Transcranial Magnetic Stimulation (TMS) has been shown to be a useful therapy for depress...
This Coverage Policy Analysis is intended to provide a summary for payers of recent evidence and cov...
Background: Repetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, noninv...
AbstractBackgroundRepetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, ...
Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depr...
ObjectiveRepetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of M...
Background: It is estimated that major depression disorders constitute 8.2 of years lived with disab...
Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiv...
This is a cost effectiveness model for evaluating the cost effectiveness of rTMS versus pharmacother...
Although effective in major depressive disorder (MDD), repetitive transcranial magnetic stimulation ...
tion (TMS) is a noninvasive and easily toler-ated method of altering cortical physiology. The author...
International audienceIntroduction Depression is among the most widespread psychiatric disorders in ...
Background: Transcranial Magnetic Stimulation (TMS) has emerged as a valid therapeutic option in the...
BackgroundRepetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment for dep...
AbstractBackgroundPrefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6...
Objective: Transcranial Magnetic Stimulation (TMS) has been shown to be a useful therapy for depress...
This Coverage Policy Analysis is intended to provide a summary for payers of recent evidence and cov...
Background: Repetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, noninv...
AbstractBackgroundRepetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, ...
Repetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of Major Depr...
ObjectiveRepetitive Transcranial Magnetic Stimulation (rTMS) commonly is used for the treatment of M...
Background: It is estimated that major depression disorders constitute 8.2 of years lived with disab...
Transcranial magnetic stimulation (TMS) is a non-invasive method of brain stimulation that is receiv...
This is a cost effectiveness model for evaluating the cost effectiveness of rTMS versus pharmacother...
Although effective in major depressive disorder (MDD), repetitive transcranial magnetic stimulation ...
tion (TMS) is a noninvasive and easily toler-ated method of altering cortical physiology. The author...
International audienceIntroduction Depression is among the most widespread psychiatric disorders in ...
Background: Transcranial Magnetic Stimulation (TMS) has emerged as a valid therapeutic option in the...
BackgroundRepetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment for dep...
AbstractBackgroundPrefrontal Transcranial Magnetic Stimulation (TMS) therapy repeated daily over 4–6...
Objective: Transcranial Magnetic Stimulation (TMS) has been shown to be a useful therapy for depress...
This Coverage Policy Analysis is intended to provide a summary for payers of recent evidence and cov...